Last edition
News about
Akums's Hormonal Plant Gets EAEU GMP Nod, Expands into Eurasia
Akums’s Hormonal Plant receives EAEU GMP certification for oral hormonal tablets, enabling entry into Eurasian markets with therapies for women’s health, HRT and endocrine care.
Bayer Expands Global Life Sciences Incubator With Launch Of Co.Lab AdVenture
Bayer has launched Co.Lab AdVenture, a new platform under its global life sciences incubator network, designed to connect high-potential biotech start-ups with leading venture capital partners worldwide.
Amgen and Kyowa Kirin Report Phase-III Results for Rocatinlimab in Atopic Dermatitis
Amgen and Kyowa Kirin report top-line results from ongoing ASCEND study evaluating Rocatinlimab’s long-term safety and efficacy in adults with moderate to severe Atopic Dermatitis following prior ROCKET trials.
Made Scientific, Hemogenyx Partner to Advance CAR-T Cell Therapy for AML
Made Scientific and Hemogenyx Pharmaceuticals have announced a technology transfer and manufacturing partnership to advance HG-CT-1, an autologous CAR-T cell therapy for acute myeloid leukaemia (AML).
Alembic Pharmaceuticals Secures USFDA Final Approval for Phytonadione Injectable Emulsion
Alembic Pharmaceuticals has received final USFDA approval for its Phytonadione Injectable Emulsion USP, 1 mg/0.5 mL Single-Dose Prefilled Syringe, used in treating and preventing vitamin K deficiency-related conditions.
Novartis to Acquire Tourmaline Bio for USD 48 per share
Novartis to acquire Tourmaline Bio in a USD 1.4 billion deal, gaining rights to pacibekitug—an anti-IL-6 antibody with potential in cardiovascular disease; transaction expected to close in Q4 2025.
Supreme Court Questions Enforcement Of Uniform Code For Pharma Marketing Practices
The query arose during the hearing of a petition filed by the Federation of Medical and Sales Representatives Association of India (FMRAI), which has long demanded that the Code be made legally binding on the pharmaceutical industry.
Strides Pharma Announces Strategic US Nasal Spray Collaboration With Kenox
In a bid to strengthen its presence in the US nasal drug delivery market, Strides Pharma Global Pte. Limited—a wholly owned Singapore subsidiary of Strides Pharma Science—has entered into a strategic product development partnership with Kenox Pharmaceuticals Inc.
Ichnos Glenmark Innovation Secures USD 700M Upfront in AbbVie Licensing Deal for ISB 2001
Ichnos Glenmark Innovation (IGI) has received an upfront payment of USD 700 million from AbbVie under the terms of their recently announced global licensing agreement for IGI’s lead investigational asset, ISB 2001.
Indegene Expands India Footprint with New Centre in Pune
Indegene, a digital-first life sciences commercialisation company, has expanded its India footprint with the launch of a new centre in Pune.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy